| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 15 |
| 1 | ETONOGESTREL | 10 |
| 2 | INFLIXIMAB | 8 |
| 3 | CYCLOPHOSPHAMIDE | 7 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 7 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 7 |
| 6 | PACLITAXEL | 7 |
| 7 | TRASTUZUMAB | 7 |
| 8 | ABATACEPT | 6 |
| 9 | ADALIMUMAB-AATY | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TETRAHYDROZOLINE HYDROCHLORIDE | 1 | 0.0034 |
| 1 | CHORIONIC GONADOTROPIN | 1 | 0.0018 |
| 2 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 3 | 0.0011 |
| 3 | CABOTEGRAVIR SODIUM | 1 | 0.0006 |
| 4 | GOLIMUMAB | 5 | 0.0004 |
| 5 | ANAKINRA | 6 | 0.0004 |
| 6 | DANAZOL | 1 | 0.0004 |
| 7 | MISOPROSTOL | 2 | 0.0002 |
| 8 | LISDEXAMFETAMINE DIMESYLATE CAPSULES | 1 | 0.0002 |
| 9 | ZIDOVUDINE | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 6 | 0.0004 |
| 1 | Interleukin-17A Antagonist [EPC] | 6 | 0.0002 |
| 2 | Prostaglandin E1 Analog [EPC] | 2 | 0.0001 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 7 | 0.0001 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 5 | Copper-containing Intrauterine Device [EPC] | 4 | 0.0001 |
| 6 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0001 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 7 | 0.0001 |